Cargando…
Co-Delivery of Letrozole and Cyclophosphamide via Folic Acid-Decorated Nanoniosomes for Breast Cancer Therapy: Synergic Effect, Augmentation of Cytotoxicity, and Apoptosis Gene Expression
Breast cancer is one of the most prevalent causes of cancer mortality in women. In order to increase patient prognosis and survival rates, new technologies are urgently required to deliver therapeutics in a more effective and efficient manner. Niosome nanoparticles have been recently employed as the...
Autores principales: | Sahrayi, Hamidreza, Hosseini, Elham, Karimifard, Sara, Khayam, Nazanin, Meybodi, Seyed Mohammadmahdi, Amiri, Sahar, Bourbour, Mahsa, Farasati Far, Bahareh, Akbarzadeh, Iman, Bhia, Mohammed, Hoskins, Clare, Chaiyasut, Chaiyavat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780158/ https://www.ncbi.nlm.nih.gov/pubmed/35056063 http://dx.doi.org/10.3390/ph15010006 |
Ejemplares similares
-
Folic Acid-Decorated pH-Responsive Nanoniosomes With Enhanced Endocytosis for Breast Cancer Therapy: In Vitro Studies
por: Rezaei, Tahereh, et al.
Publicado: (2022) -
In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment
por: Ahmadi, Saeedeh, et al.
Publicado: (2022) -
Ciprofloxacin-Loaded Titanium Nanotubes Coated with Chitosan: A Promising Formulation with Sustained Release and Enhanced Antibacterial Properties
por: Asadi, Soada, et al.
Publicado: (2022) -
A comparative study on biopharmaceutical function of curcumin and miR-34a by multistimuli-responsive nanoniosome carrier: In-vitro and in-vivo
por: Abtahi, Najmeh Alsadat, et al.
Publicado: (2022) -
Artificial intelligence ethics in precision oncology: balancing advancements in technology with patient privacy and autonomy
por: Farasati Far, Bahareh
Publicado: (2023)